Pharmaceuticals, Biotechnology and Life Sciences
Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active treatment arms compared to placebo,…
Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this NovemberTORONTO and…
Buffalo, NY, July 25, 2025 (GLOBE NEWSWIRE) — POP Biotechnologies (POP BIO), a biotechnology company specializing in nanoparticle-based vaccines, and…
The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol…
The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol…
COPENHAGEN, Denmark, July 25, 2025 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered…
VYJUVEK approved for the treatment of DEB from birth with flexible administration options including home dosing and the option for…
Strategic Internal Review initiated for treasury diversification through a prospective digital asset subsidiary — no entity formed, no capital committedLA…
CONSHOHOCKEN, Pa., July 25, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel…
Proceeds to Fund Completion of the Company’s 510k Filing with the U.S. FDA for its Fingerprint Drug Screening SystemNEW YORK,…